Clinical Trial Update: Action of Amantadine on Post-Stroke Aphasic Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluated amantadine for language recovery in post-stroke aphasia due to cerebral infarction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Cerebral Infarction

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Cerebral Infarction | Phase 2, Phase 3 | Status: COMPLETED